Johnson & Johnson makes prescription medicines and medical devices for hospitals, doctors and eye care professionals. It last closed at $270.47 on Nov 20, up 1.25% on the day. The next earnings report for JNJ is expected around Wed, Jan 20, 2027. For the quarter ended Sep 2026, JNJ reported EPS of $0.09 on revenue of $25.40B, with revenue up 5.9% from a year ago. Over its last 8 reports the stock moved an average of 2.3% the session after earnings. Over the last 12 months JNJ insiders bought $258K of stock on the open market and sold $154.4M, according to SEC Form 4 filings.
AI Auto Pilots
Is JNJ in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold JNJ.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on JNJStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
JNJ · as of the Nov 20 close · updated each morning
Moving sideways
The stock sits between its 20 and 50 day averages. It is 7% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 48). The nearest support is the Pivot S1 at $269.13, and the nearest resistance the Pivot at $270.81.
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 2.5%/day
Key levels
$290.2552 week high+7.3%
$275.0120 day average+1.7%
$272.16Pivot R1+0.6%
$271.55Swing high (Sep 14)+0.4%
$270.81Pivot+0.1%
$270.47Last close
$269.13Pivot S1−0.5%
$267.4350 day average−1.1%
$265.28Swing low (Nov 3)−1.9%
$265.07100 day average−2.0%
$250.83200 day average−7.3%
$199.9152 week low−26.1%
Indicators
RSI (14)
48.11
Middle of its range
Neutral
MACD
2.48
Below its signal line
Bearish
Stochastic
20.7
Middle of its range
Neutral
ADX (14)
21.8
Weak trend
Williams %R
-77.4
Oversold below −80, overbought above −20
Neutral
CCI (20)
-58.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−2.1%
Change over 10 sessions
Bearish
ATR (14)
$6.70
Typical daily range, 2.5% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Uptrend
Short trendBullish
Long trendBullish
MomentumNeutral
StretchNormal
VolatilityHigh, 5.4%/day
Key levels
$290.2552 week high+7.3%
$275.0120 day average+1.7%
$272.16Pivot R1+0.6%
$271.55Swing high (Sep 14)+0.4%
$270.81Pivot+0.1%
$270.47Last close
$269.13Pivot S1−0.5%
$267.4350 day average−1.1%
$265.28Swing low (Nov 3)−1.9%
$265.07100 day average−2.0%
$250.83200 day average−7.3%
$199.9152 week low−26.1%
Indicators
RSI (14)
55.85
Middle of its range
Neutral
MACD
9.02
Below its signal line
Bearish
Stochastic
78.3
Middle of its range
Neutral
ADX (14)
28.6
Trending up
Williams %R
-43.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
94.9
Oversold below −100, overbought above 100
Neutral
Rate of change
+1.8%
Change over 10 sessions
Bullish
ATR (14)
$14.71
Typical daily range, 5.4% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for JNJ
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how JNJ did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow JNJ usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for JNJHow many large options trades hit JNJ, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in JNJ in the last 90 days.
From SEC Form 4 filings by JNJ's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Oct 21, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether JNJ is in one of them and how their past JNJ trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Johnson & Johnson
Johnson & Johnson is a healthcare company based in New Brunswick, New Jersey, that researches, makes and sells medicines and medical devices. Its Innovative Medicine business offers prescription drugs for conditions such as cancer, immune disorders, mental health conditions, HIV and pulmonary arterial hypertension. Its MedTech business supplies products for heart care, surgery, orthopaedic procedures and vision care. Its customers include hospitals, doctors, retailers, wholesalers and eye care professionals, and it sells in virtually all countries.